This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (96)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

M. H. Prins, MD; J Hirsh, MD

Arch Intern Med. 1991;151(9):1721-1731.

Abstract
We critically evaluated the evidence for an association between venous thromboembolism and impaired fibrinolytic activity, as determined by global tests of fibrinolytic activity or specific tests for tissue plasminogen activator and plasminogen activator inhibitor. A computer-assisted and manual search was performed to retrieve all articles that reported on fibrinolytic activity and venous thromboembolism. The strength of the evidence for an association was assessed by analysis of the design of individual studies with special attention directed to choice of controls and methods of diagnosis of venous thromboembolism. It is concluded that for patients with symptomatic thrombosis the published evidence does not prove an association between impaired fibrinolytic activity and increased risk of thrombosis. In contrast, for postoperative thrombosis there is good evidence for an association between impaired fibrinolytic activity measured either preoperatively or postoperatively and increased risk of postoperative thrombosis. Whether this association is causal or coincidental is unclear, since randomized clinical trials that used interventions to enhance fibrinolytic activity produced inconsistent results.

(Arch Intern Med. 1991;151:1721-1731)

Author Affiliations
From the Department of Medicine, McMaster University, and the Hamilton Civic Hospital Research Center, Hamilton, Ontario. Reprints not available.

Footnotes
Accepted for publication April 8, 1991.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pulmonary Embolism and Pulmonary Thromboendarterectomy
Madani and Jamieson
Card Surg Adult 2008;3:1309-1332.
FULL TEXT  

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
Lisman et al.
Blood 2005;105:1102-1105.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Monagle et al.
Chest 2004;126:645S-687S.
ABSTRACT | FULL TEXT  

An Association between Atherosclerosis and Venous Thrombosis
Prandoni et al.
NEJM 2003;348:1435-1441.
ABSTRACT | FULL TEXT  

Fibrin fragment D-dimer and the risk of future venous thrombosis
Cushman et al.
Blood 2003;101:1243-1248.
ABSTRACT | FULL TEXT  

Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System
Crowther and Kelton
ANN INTERN MED 2003;138:128-134.
ABSTRACT | FULL TEXT  

Pulmonary Thromboendarterectomy
Madani and Jamieson
Card Surg Adult 2003;2:1205-1228.
FULL TEXT  

Antithrombotic Therapy in Children
Monagle et al.
Chest 2001;119 :344S-370S.
FULL TEXT  

Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
Wilder-Smith et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:351-356.
ABSTRACT | FULL TEXT  

Plasminogen Activator Inhibitor Type 1 and Tissue Inhibitor of Metalloproteinases-2 Increase After Arterial Injury in Rats
Hasenstab et al.
Circ. Res. 1997;80:490-496.
ABSTRACT | FULL TEXT  

Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association
Hirsh and Hoak
Circulation 1996;93:2212-2245.
FULL TEXT  

The Distal Hinge of the Reactive Site Loop and Its Proximity. A TARGET TO MODULATE PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY
Bijnens et al.
J. Biol. Chem. 2001;276:44912-44918.
ABSTRACT | FULL TEXT